PlainRecalls
FDA Devices Moderate Class II Completed

MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System

Reported: October 20, 2021 Initiated: September 2, 2021 #Z-0084-2022

Product Description

MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System

Reason for Recall

Under certain conditions, there is a risk for a false negative result.

Details

Recalling Firm
BioMerieux SA
Units Affected
542 units
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Austria, Australia, Belgium, Canada, Switzerland, Chile, Columbia, Czech Republic, Denmark, Germany, Spain, Finland, France, United Kingdom, Guadeloupe, Hong Kong, Canary Islands, Ireland, India, Italy, Japan, South Korea, The Netherlands, Norway, Poland, Portugal, Sweden, Singapore, South Africa.
Location
La Balme les Grottes, N/A

Frequently Asked Questions

What product was recalled?
MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System. Recalled by BioMerieux SA. Units affected: 542 units.
Why was this product recalled?
Under certain conditions, there is a risk for a false negative result.
Which agency issued this recall?
This recall was issued by the FDA Devices on October 20, 2021. Severity: Moderate. Recall number: Z-0084-2022.